These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 7737276)

  • 1. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway.
    Isaaz S; Baetz K; Olsen K; Podack E; Griffiths GM
    Eur J Immunol; 1995 Apr; 25(4):1071-9. PubMed ID: 7737276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of lymphocyte-mediated cytolysis: functional cytolytic T cells lacking perforin and granzymes.
    Berke G; Rosen D; Ronen D
    Immunology; 1993 Jan; 78(1):105-12. PubMed ID: 8436395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of primary T lymphocytes results in lysosome development and polarized granule exocytosis in CD4+ and CD8+ subsets, whereas expression of lytic molecules confers cytotoxicity to CD8+ T cells.
    Shen DT; Ma JS; Mather J; Vukmanovic S; Radoja S
    J Leukoc Biol; 2006 Oct; 80(4):827-37. PubMed ID: 16891618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of granule proteins in T-cell-mediated cytolysis.
    Krähenbühl O; Tschopp J
    Nat Immun Cell Growth Regul; 1990; 9(4):274-82. PubMed ID: 2215515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
    Bochan MR; Goebel WS; Brahmi Z
    Cell Immunol; 1995 Sep; 164(2):234-9. PubMed ID: 7656332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K; Akashi A; Arai S
    Cell Immunol; 1998 May; 185(2):114-22. PubMed ID: 9636689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes.
    Lancki DW; Hsieh CS; Fitch FW
    J Immunol; 1991 May; 146(9):3242-9. PubMed ID: 1673149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ; Costelloe EO; Fitzpatrick DR; Haanen JB; Schumacher TN; Brown LE; Kelso A
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2657-62. PubMed ID: 12601154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of mouse cytotoxic T lymphocyte with an antisense granzyme A vector reduces lytic activity.
    Talento A; Nguyen M; Law S; Wu JK; Poe M; Blake JT; Patel M; Wu TJ; Manyak CL; Silberklang M
    J Immunol; 1992 Dec; 149(12):4009-15. PubMed ID: 1460287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
    Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
    J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a granule-independent lytic mechanism used by CTL hybridomas.
    Garner R; Helgason CD; Atkinson EA; Pinkoski MJ; Ostergaard HL; Sorensen O; Fu A; Lapchak PH; Rabinovitch A; McElhaney JE
    J Immunol; 1994 Dec; 153(12):5413-21. PubMed ID: 7527440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro.
    Berke G; Rosen D
    J Immunol; 1988 Sep; 141(5):1429-36. PubMed ID: 3261748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appearance of granule-associated molecules during activation of cytolytic T-lymphocyte precursors by defined stimuli.
    Garcia-Sanz JA; Velotti F; MacDonald HR; Masson D; Tschopp J; Nabholz M
    Immunology; 1988 May; 64(1):129-34. PubMed ID: 3260214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood.
    Bratke K; Kuepper M; Bade B; Virchow JC; Luttmann W
    Eur J Immunol; 2005 Sep; 35(9):2608-16. PubMed ID: 16106370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid loss of perforin and serine protease RNA in cytotoxic lymphocytes exposed to sensitive targets.
    Bajpai A; Kwon BS; Brahmi Z
    Immunology; 1991 Oct; 74(2):258-63. PubMed ID: 1721042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
    Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
    J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CPP32-like proteases prevents granzyme B- and Fas-, but not granzyme A-based cytotoxicity exerted by CTL clones.
    Anel A; Gamen S; Alava MA; Schmitt-Verhulst AM; Piñeiro A; Naval J
    J Immunol; 1997 Mar; 158(5):1999-2006. PubMed ID: 9036942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.